News

 

 

Date

Title

October 1, 2020

Euclises Press Release Announcing Clearance of US IND

May 18, 2020

Euclises Press Release Changming License Agreement

March 28, 2017

Euclises Pharmaceuticals, Inc. to Present Preclinical Efficacy Results at American Association for Cancer Research

January 11, 2016

COX-2 Inhibitor Drug offering hope in Treating Colorectal and Non-Small Cell Lung Cancer in avoiding GI Side(...)

January 5, 2016

Euclies Pharmaceuticals to Present at Biotech Showcase in SAN FRANCISCO

January 27, 2015

Euclises announces appointment of Bobby Sandage as new CEO

February 16, 2015

Euclises Featured as Emerging Company in BioCentury

April 7, 2015

Euclises completes financing round

May 19, 2015

Euclises co-founder named 2015 power medicine maker

December 9, 2015

Receives Notice of Patent Allowance from European Patent Office for New Class of Compounds for Treatment of(...)

September 9, 2014

Euclises announces series A financing

December 3, 2014

Euclises announces development agreement with GIBH